Author: Henrina, Joshua; Putra, Iwan Cahyo Santosa; Lawrensia, Sherly; Marta, Della Sabrina; Wijaya, Ellen; Saboe, Aninka; Cool, Charlotte Johanna; Suciadi, Leonardo Paskah
Title: Cardiac Manifestations, Treatment Characteristics, and Outcomes of Paediatric Inflammatory Multisystem Syndrome Temporally Associated with Severe Acute Respiratory Syndrome Coronavirus-2: systematic review of case reports and case series Cord-id: lrn53pan Document date: 2021_2_9
ID: lrn53pan
Snippet: Objective To investigate cardiac manifestations, treatment characteristics, and outcomes of paediatric inflammatory multisystem syndrome (PIMS) temporally associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (PIMS-TS) Method We performed a comprehensive literature search of several databases and qualitatively synthesized findings from studies. Results Twenty-six studies were included with 1228 pooled subjects, with a mean age of 8.6 years, which were dominated by male gen
Document: Objective To investigate cardiac manifestations, treatment characteristics, and outcomes of paediatric inflammatory multisystem syndrome (PIMS) temporally associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (PIMS-TS) Method We performed a comprehensive literature search of several databases and qualitatively synthesized findings from studies. Results Twenty-six studies were included with 1228 pooled subjects, with a mean age of 8.6 years, which were dominated by male gender (53%), and African ethnicity (31%). 732 (38%) patients were reactive on a serological test, and 457 patients (45%) were positive on SARS-CoV-2 RT-PCR. ST-segment abnormalities were the most common ECG findings (16%, n/N: 34/212). Various markers of troponin and the pooled mean of BNP and NT-pro-BNP levels were elevated. Cardiomegaly and pericardial effusion (21.8%, n/N: 164/751) was the most common chest X-ray findings. In echocardiography, the majority of patients’ left ventricular ejection fraction was reduced (59.0%, n/N: 180/305), with pericardial effusion/ pericarditis seen the most (17.44%, n/N: 221/1267), and Z score ≥ 2 in 28% (n/N: 42/139). Cardiac MRI findings were consistent with acute myocarditis. Intravenous immunoglobulin, corticosteroids, and vasoactive drugs were frequently utilized. The mean length of stay was 6 days, with most patients (71%, n/N: 834/1163) were admitted to the ICU. However, the overall prognosis was favourable, with 98% alive (n/N: 1235/1260), and more than 50% of patients experienced recovery of left ventricular systolic functions at discharge (116 out of 206 patients). Conclusion PIMS-TS is a rare clinical syndrome associated with a multiorgan system dysfunction, especially acute cardiac injury, and mandates a higher level of care. Nevertheless, when appropriate treatments are available, the cardiac function rapidly reverted to normal in most cases, and it was associated with a favourable outcome in general. Of concern, medium and long-term prognosis remains to be elucidated.
Search related documents:
Co phrase search for related documents- acute infection and adaptive immune response activation: 1
- acute infection and long medium: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and long medium term: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and long medium term follow: 1
- acute infection and low inflammatory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute infection and low inflammatory dose: 1
- acute infection and lung oedema: 1
- acute infection and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65
- acute respiratory syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and adaptive immune response activation: 1, 2, 3, 4, 5
- acute respiratory syndrome and long medium: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory syndrome and long medium term: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and low inflammatory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- acute respiratory syndrome and low inflammatory dose: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome and lung oedema: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- adaptive immune response activation and low inflammatory: 1
- adaptive immune response and low inflammatory: 1, 2, 3, 4, 5
- long medium and lung oedema: 1
Co phrase search for related documents, hyperlinks ordered by date